1h Free Analyst Time
The global chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7.94 billion during 2025-2030, accelerating at a CAGR of 6.2% during the forecast period. The report on the global chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of copd, strong pipeline and new drug approvals, growing demand for fixed-dose combinations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global chronic obstructive pulmonary disease drugs market is segmented as below:
By Product
- Combination therapy
- Monotherapy
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Inhalation
- Oral
- Injectable
By Disease Type
- Chronic bronchitis
- Emphysema
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- The Netherlands
- Spain
- Asia
- Rest of World (RoW)
The report on the global chronic obstructive pulmonary disease drugs market covers the following areas:
- Global chronic obstructive pulmonary disease drugs market sizing
- Global chronic obstructive pulmonary disease drugs market forecast
- Global chronic obstructive pulmonary disease drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Global Chronic Obstructive Pulmonary Disease Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product
8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Combination therapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Combination therapy - Market size and forecast 2025-2030 ($ million)
- Chart on Combination therapy - Year-over-year growth 2025-2030 (%)
- Data Table on Combination therapy - Year-over-year growth 2025-2030 (%)
- Chart on Monotherapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Monotherapy - Market size and forecast 2025-2030 ($ million)
- Chart on Monotherapy - Year-over-year growth 2025-2030 (%)
- Data Table on Monotherapy - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
- Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
- Chart on Inhalation - Year-over-year growth 2025-2030 (%)
- Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Disease Type
11.1 Market segments
- Chart on Disease Type - Market share 2025-2030 (%)
- Data Table on Disease Type - Market share 2025-2030 (%)
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
- Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
- Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
- Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
- Chart on Emphysema - Market size and forecast 2025-2030 ($ million)
- Data Table on Emphysema - Market size and forecast 2025-2030 ($ million)
- Chart on Emphysema - Year-over-year growth 2025-2030 (%)
- Data Table on Emphysema - Year-over-year growth 2025-2030 (%)
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Rising prevalence of COPD
- Strong pipeline and new drug approvals
- Growing demand for fixed-dose combinations
- Low diagnosis rates of diseases
- High cost of conducting clinical trials
- Obstacles to reimbursement
- Impact of drivers and challenges in 2025 and 2030
- Expanding research in curative approaches
- Advances in drug delivery devices
- Rising expansion of inhalation therapies
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key news
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- Innoviva Inc. - Overview
- Innoviva Inc. - Product / Service
- Innoviva Inc. - Key news
- Innoviva Inc. - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- SHIONOGI Co. Ltd. - Overview
- SHIONOGI Co. Ltd. - Product / Service
- SHIONOGI Co. Ltd. - Key offerings
- SWOT
- Sumitomo Pharma Co. Ltd. - Overview
- Sumitomo Pharma Co. Ltd. - Business segments
- Sumitomo Pharma Co. Ltd. - Key offerings
- Sumitomo Pharma Co. Ltd. - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Theravance Biopharma Inc. - Overview
- Theravance Biopharma Inc. - Product / Service
- Theravance Biopharma Inc. - Key offerings
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Product - Market share 2025-2030 (%)
Exhibit 41: Data Table on Product - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Product
Exhibit 43: Data Table on Comparison by Product
Exhibit 44: Chart on Combination therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Combination therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Combination therapy - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Combination therapy - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Monotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Monotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Monotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Monotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Product ($ million)
Exhibit 53: Data Table on Market opportunity by Product ($ million)
Exhibit 54: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 55: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Distribution Channel
Exhibit 57: Data Table on Comparison by Distribution Channel
Exhibit 58: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Market opportunity by Distribution Channel ($ million)
Exhibit 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 72: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 73: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 74: Chart on Comparison by Route of Administration
Exhibit 75: Data Table on Comparison by Route of Administration
Exhibit 76: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Route of Administration ($ million)
Exhibit 89: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 90: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 91: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by Disease Type
Exhibit 93: Data Table on Comparison by Disease Type
Exhibit 94: Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Emphysema - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Emphysema - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Emphysema - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Emphysema - Year-over-year growth 2025-2030 (%)
Exhibit 102: Market opportunity by Disease Type ($ million)
Exhibit 103: Data Table on Market opportunity by Disease Type ($ million)
Exhibit 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 105: Chart on Market share by geography 2025-2030 (%)
Exhibit 106: Data Table on Market share by geography 2025-2030 (%)
Exhibit 107: Chart on Geographic comparison
Exhibit 108: Data Table on Geographic comparison
Exhibit 109: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Regional Comparison - North America
Exhibit 114: Data Table on Regional Comparison - North America
Exhibit 115: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Regional Comparison - Europe
Exhibit 132: Data Table on Regional Comparison - Europe
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 200: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 225: Market opportunity by geography ($ million)
Exhibit 226: Data Tables on Market opportunity by geography ($ million)
Exhibit 227: Impact of drivers and challenges in 2025 and 2030
Exhibit 228: Overview on criticality of inputs and factors of differentiation
Exhibit 229: Overview on factors of disruption
Exhibit 230: Impact of key risks on business
Exhibit 231: Companies covered
Exhibit 232: Company ranking index
Exhibit 233: Matrix on companies position and classification
Exhibit 234: AstraZeneca Plc - Overview
Exhibit 235: AstraZeneca Plc - Product / Service
Exhibit 236: AstraZeneca Plc - Key news
Exhibit 237: AstraZeneca Plc - Key offerings
Exhibit 238: SWOT
Exhibit 239: Boehringer Ingelheim GmbH - Overview
Exhibit 240: Boehringer Ingelheim GmbH - Product / Service
Exhibit 241: Boehringer Ingelheim GmbH - Key news
Exhibit 242: Boehringer Ingelheim GmbH - Key offerings
Exhibit 243: SWOT
Exhibit 244: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 245: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 246: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 247: SWOT
Exhibit 248: Cipla Inc. - Overview
Exhibit 249: Cipla Inc. - Business segments
Exhibit 250: Cipla Inc. - Key news
Exhibit 251: Cipla Inc. - Key offerings
Exhibit 252: Cipla Inc. - Segment focus
Exhibit 253: SWOT
Exhibit 254: GlaxoSmithKline Plc - Overview
Exhibit 255: GlaxoSmithKline Plc - Business segments
Exhibit 256: GlaxoSmithKline Plc - Key news
Exhibit 257: GlaxoSmithKline Plc - Key offerings
Exhibit 258: GlaxoSmithKline Plc - Segment focus
Exhibit 259: SWOT
Exhibit 260: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 261: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 262: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 263: SWOT
Exhibit 264: Innoviva Inc. - Overview
Exhibit 265: Innoviva Inc. - Product / Service
Exhibit 266: Innoviva Inc. - Key news
Exhibit 267: Innoviva Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Lupin Ltd. - Overview
Exhibit 270: Lupin Ltd. - Business segments
Exhibit 271: Lupin Ltd. - Key news
Exhibit 272: Lupin Ltd. - Key offerings
Exhibit 273: Lupin Ltd. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Merck and Co. Inc. - Overview
Exhibit 276: Merck and Co. Inc. - Business segments
Exhibit 277: Merck and Co. Inc. - Key news
Exhibit 278: Merck and Co. Inc. - Key offerings
Exhibit 279: Merck and Co. Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Novartis AG - Overview
Exhibit 282: Novartis AG - Business segments
Exhibit 283: Novartis AG - Key news
Exhibit 284: Novartis AG - Key offerings
Exhibit 285: Novartis AG - Segment focus
Exhibit 286: SWOT
Exhibit 287: SHIONOGI Co. Ltd. - Overview
Exhibit 288: SHIONOGI Co. Ltd. - Product / Service
Exhibit 289: SHIONOGI Co. Ltd. - Key offerings
Exhibit 290: SWOT
Exhibit 291: Sumitomo Pharma Co. Ltd. - Overview
Exhibit 292: Sumitomo Pharma Co. Ltd. - Business segments
Exhibit 293: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibit 294: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibit 295: SWOT
Exhibit 296: Teva Pharmaceutical Ltd. - Overview
Exhibit 297: Teva Pharmaceutical Ltd. - Business segments
Exhibit 298: Teva Pharmaceutical Ltd. - Key news
Exhibit 299: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 300: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Theravance Biopharma Inc. - Overview
Exhibit 303: Theravance Biopharma Inc. - Product / Service
Exhibit 304: Theravance Biopharma Inc. - Key offerings
Exhibit 305: SWOT
Exhibit 306: Viatris Inc. - Overview
Exhibit 307: Viatris Inc. - Business segments
Exhibit 308: Viatris Inc. - Key news
Exhibit 309: Viatris Inc. - Key offerings
Exhibit 310: Viatris Inc. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Inclusions checklist
Exhibit 313: Exclusions checklist
Exhibit 314: Currency conversion rates for US$
Exhibit 315: Research methodology
Exhibit 316: Information sources
Exhibit 317: Data validation
Exhibit 318: Validation techniques employed for market sizing
Exhibit 319: Data synthesis
Exhibit 320: 360 degree market analysis
Exhibit 321: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Product - Market share 2025-2030 (%)
Exhibit 41: Data Table on Product - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Product
Exhibit 43: Data Table on Comparison by Product
Exhibit 44: Chart on Combination therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Combination therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Combination therapy - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Combination therapy - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Monotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Monotherapy - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Monotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Monotherapy - Year-over-year growth 2025-2030 (%)
Exhibit 52: Market opportunity by Product ($ million)
Exhibit 53: Data Table on Market opportunity by Product ($ million)
Exhibit 54: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 55: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 56: Chart on Comparison by Distribution Channel
Exhibit 57: Data Table on Comparison by Distribution Channel
Exhibit 58: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 62: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 63: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 65: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 66: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 67: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 68: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Market opportunity by Distribution Channel ($ million)
Exhibit 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 72: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 73: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 74: Chart on Comparison by Route of Administration
Exhibit 75: Data Table on Comparison by Route of Administration
Exhibit 76: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Route of Administration ($ million)
Exhibit 89: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 90: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 91: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by Disease Type
Exhibit 93: Data Table on Comparison by Disease Type
Exhibit 94: Chart on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Chronic bronchitis - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Chronic bronchitis - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Emphysema - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Emphysema - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Emphysema - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Emphysema - Year-over-year growth 2025-2030 (%)
Exhibit 102: Market opportunity by Disease Type ($ million)
Exhibit 103: Data Table on Market opportunity by Disease Type ($ million)
Exhibit 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 105: Chart on Market share by geography 2025-2030 (%)
Exhibit 106: Data Table on Market share by geography 2025-2030 (%)
Exhibit 107: Chart on Geographic comparison
Exhibit 108: Data Table on Geographic comparison
Exhibit 109: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Regional Comparison - North America
Exhibit 114: Data Table on Regional Comparison - North America
Exhibit 115: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Regional Comparison - Europe
Exhibit 132: Data Table on Regional Comparison - Europe
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 200: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 225: Market opportunity by geography ($ million)
Exhibit 226: Data Tables on Market opportunity by geography ($ million)
Exhibit 227: Impact of drivers and challenges in 2025 and 2030
Exhibit 228: Overview on criticality of inputs and factors of differentiation
Exhibit 229: Overview on factors of disruption
Exhibit 230: Impact of key risks on business
Exhibit 231: Companies covered
Exhibit 232: Company ranking index
Exhibit 233: Matrix on companies position and classification
Exhibit 234: AstraZeneca Plc - Overview
Exhibit 235: AstraZeneca Plc - Product / Service
Exhibit 236: AstraZeneca Plc - Key news
Exhibit 237: AstraZeneca Plc - Key offerings
Exhibit 238: SWOT
Exhibit 239: Boehringer Ingelheim GmbH - Overview
Exhibit 240: Boehringer Ingelheim GmbH - Product / Service
Exhibit 241: Boehringer Ingelheim GmbH - Key news
Exhibit 242: Boehringer Ingelheim GmbH - Key offerings
Exhibit 243: SWOT
Exhibit 244: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 245: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 246: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 247: SWOT
Exhibit 248: Cipla Inc. - Overview
Exhibit 249: Cipla Inc. - Business segments
Exhibit 250: Cipla Inc. - Key news
Exhibit 251: Cipla Inc. - Key offerings
Exhibit 252: Cipla Inc. - Segment focus
Exhibit 253: SWOT
Exhibit 254: GlaxoSmithKline Plc - Overview
Exhibit 255: GlaxoSmithKline Plc - Business segments
Exhibit 256: GlaxoSmithKline Plc - Key news
Exhibit 257: GlaxoSmithKline Plc - Key offerings
Exhibit 258: GlaxoSmithKline Plc - Segment focus
Exhibit 259: SWOT
Exhibit 260: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 261: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 262: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 263: SWOT
Exhibit 264: Innoviva Inc. - Overview
Exhibit 265: Innoviva Inc. - Product / Service
Exhibit 266: Innoviva Inc. - Key news
Exhibit 267: Innoviva Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Lupin Ltd. - Overview
Exhibit 270: Lupin Ltd. - Business segments
Exhibit 271: Lupin Ltd. - Key news
Exhibit 272: Lupin Ltd. - Key offerings
Exhibit 273: Lupin Ltd. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Merck and Co. Inc. - Overview
Exhibit 276: Merck and Co. Inc. - Business segments
Exhibit 277: Merck and Co. Inc. - Key news
Exhibit 278: Merck and Co. Inc. - Key offerings
Exhibit 279: Merck and Co. Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Novartis AG - Overview
Exhibit 282: Novartis AG - Business segments
Exhibit 283: Novartis AG - Key news
Exhibit 284: Novartis AG - Key offerings
Exhibit 285: Novartis AG - Segment focus
Exhibit 286: SWOT
Exhibit 287: SHIONOGI Co. Ltd. - Overview
Exhibit 288: SHIONOGI Co. Ltd. - Product / Service
Exhibit 289: SHIONOGI Co. Ltd. - Key offerings
Exhibit 290: SWOT
Exhibit 291: Sumitomo Pharma Co. Ltd. - Overview
Exhibit 292: Sumitomo Pharma Co. Ltd. - Business segments
Exhibit 293: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibit 294: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibit 295: SWOT
Exhibit 296: Teva Pharmaceutical Ltd. - Overview
Exhibit 297: Teva Pharmaceutical Ltd. - Business segments
Exhibit 298: Teva Pharmaceutical Ltd. - Key news
Exhibit 299: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 300: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Theravance Biopharma Inc. - Overview
Exhibit 303: Theravance Biopharma Inc. - Product / Service
Exhibit 304: Theravance Biopharma Inc. - Key offerings
Exhibit 305: SWOT
Exhibit 306: Viatris Inc. - Overview
Exhibit 307: Viatris Inc. - Business segments
Exhibit 308: Viatris Inc. - Key news
Exhibit 309: Viatris Inc. - Key offerings
Exhibit 310: Viatris Inc. - Segment focus
Exhibit 311: SWOT
Exhibit 312: Inclusions checklist
Exhibit 313: Exclusions checklist
Exhibit 314: Currency conversion rates for US$
Exhibit 315: Research methodology
Exhibit 316: Information sources
Exhibit 317: Data validation
Exhibit 318: Validation techniques employed for market sizing
Exhibit 319: Data synthesis
Exhibit 320: 360 degree market analysis
Exhibit 321: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global chronic obstructive pulmonary disease drugs market: AstraZeneca Plc, Boehringer Ingelheim GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., Exela Pharma Sciences LLC, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Mundipharma International Ltd., Novartis AG, Philip Morris International, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Ltd., Theravance Biopharma Inc., Vertex Pharmaceuticals Inc., Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is expanding research in curative approaches."
According to the report, one of the major drivers for this market is the rising prevalence of copd.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Boehringer Ingelheim GmbH
- Cadila Pharmaceuticals Ltd.
- CHIESI Farmaceutici SpA
- Cipla Inc.
- Exela Pharma Sciences LLC
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Innoviva Inc.
- Lupin Ltd.
- Merck and Co. Inc.
- Mundipharma International Ltd.
- Novartis AG
- Philip Morris International
- SHIONOGI Co. Ltd.
- Sumitomo Pharma Co. Ltd.
- Teva Pharmaceutical Ltd.
- Theravance Biopharma Inc.
- Vertex Pharmaceuticals Inc.
- Viatris Inc.
